TraCS Tales of Translation features experienced scientists from academia and industry discussing the many twists and turns that are a part of research careers in the life sciences. Participating scientists will be asked to speak informally about their career decisions and pivot points, what translation means to them, and their advice for early stage researchers. This week's researcher is Colin O'Banion, PhD.
O'Banion grew up in western NY and went to the University of Rochester for his undergraduate degree where he studied neuroscience. He then worked at Johns Hopkins University as a technician, studying ALS treatment. Colin attended UNC-Chapel Hill Eshelman School of Pharmacy for graduate work where he developed optogenetic tools to control cell signaling and cell based, light mediated drug delivery platforms. After his postdoc at the Max Planck Florida Institute for Neuroscience, Colin moved to industry and is now working as the scientific lead of StrideBio's Rett syndrome program developing AAV gene therapies.
There will be a Q&A session at the end.